Login / Signup

Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study.

Xiu LiuKai OuXiaoting MaLizhen GaoQi WangHaizeng ZhangLin Yang
Published in: BMC cancer (2022)
The use of the XELOXIRI regimen with or without a targeted drug was effective, with a manageable toxicity profile in Chinese patients with mCRC.
Keyphrases
  • metastatic colorectal cancer
  • cancer therapy
  • oxidative stress
  • clinical trial
  • squamous cell carcinoma
  • randomized controlled trial
  • adverse drug
  • electronic health record